• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Nurix Therapeutics, Inc. - Common stock (NQ:NRIX)

    12.94 +0.16 (+1.25%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Nurix Therapeutics, Inc. - Common stock

    < Previous 1 2 3 4 5 Next >
    10 Health Care Stocks With Whale Alerts In Today's Session
     
    Via Benzinga
    Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On?
     
    Via Benzinga
    The Latest Analyst Ratings for Nurix Therapeutics
     
    Via Benzinga
    Why Is Cancer Focused Nurix Therapeutics Stock Trading Higher Today?
    Nurix Therapeutics Inc (NASDAQ: NRIX) has entered into a multi-year, multi-target strategic collaboration agreement with Seagen Inc (NASDAQ: SGEN) to advance a new class of medicines called... 
    Via Benzinga
    What 4 Analyst Ratings Have To Say About Nurix Therapeutics
     
    Via Benzinga
    Designer Brands, Calavo Growers, Couchbase And Other Big Stocks Moving Higher On Thursday
    U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Thursday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Topics Stocks
    Analyst Ratings for Nurix Therapeutics
     
    Via Benzinga
    Nurix Therapeutics's Return On Capital Employed Insights
     
    Via Benzinga
    Analyst Cuts Nurix Therapeutics Price Target By 38%, Cites Lymphoma Data
    HC Wainwright analyst Robert Burns has lowered the price target for Nurix Therapeutics Inc (NASDAQ: NRIX)  
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    It's time to start the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday! 
    Via InvestorPlace
    Analyst Ratings for Nurix Therapeutics
     
    Via Benzinga
    JPMorgan, Citigroup, QuidelOrtho And Other Big Stocks Moving Higher On Friday
    U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Friday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Nurix Therapeutics Inc. (NASDAQ: NRIX) Highlighted for Surprising Price Action
    Via Investor Brand Network
    Expert Ratings for Nurix Therapeutics
     
    Via Benzinga
    Gilead Exercises First License Option Under Agreement With Nurix Therapeutics
     
    Via Benzinga
    Analyst Ratings for Nurix Therapeutics
     
    Via Benzinga
    Gilead Exercises Option to License Nurix’s IRAK4 Targeted Protein Degrader Development Candidate, NX-0479
    From Gilead Sciences, Inc.
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023
     
    Via Benzinga
    Nurix Therapeutics's Return On Capital Employed Overview
     
    Via Benzinga
    Where Nurix Therapeutics Stands With Analysts
    Within the last quarter, Nurix Therapeutics (NASDAQ:NRIX) has observed the following analyst ratings: 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
     
    Via Benzinga
    The Top 5 Stocks Cathie Wood Bought and Sold This Week
    Cathie Wood's flagship ETF, the ARK Innovation ETF, hit a five-year and 52-week low this week, casting doubts on the investment manager. 
    Via InvestorPlace
    CSX, Veris Residential And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
    U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
    Via Benzinga
    Cathie Wood Loads Up Over $6.7M In Adobe Stock As It Tumbles 27% In A Month — Also Adds Stake In This Biopharma Company
    Cathie Wood-led ARK Investment Management bought over 23,000 shares of software maker Adobe Inc (NASDAQ: ADBE) through the 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
    Upgrades 
    Via Benzinga
    Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday
    Gainers 
    Via Benzinga
    Top Russell 2000 Stocks: Trading Opportunities For Next Week - Sunday, Sept. 11
    A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Here is a closer look at some Russell 2000 stock... 
    Via Talk Markets
    Tesla, Twitter And 76 Biggest Movers From Friday
    Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board... 
    Via Benzinga
    Why Nurix Therapeutics Shares Are Rising Today
    Nurix Therapeutics Inc (NASDAQ: NRIX) shares are trading higher by 13.25% to $17.52 Friday afternoon after the company announced a registered direct offering for total gross proceeds of approximately... 
    Via Benzinga
    Nurix Therapeutics's Return On Capital Employed Insights
    Benzinga Pro data, Nurix Therapeutics (NASDAQ:NRIX) reported Q2 sales of $11.43 million. Earnings fell to a loss of $45.40 million, resulting in a 6.74% decrease from last quarter. 
    Via Benzinga
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.